School Attendance in Children With Functional Abdominal Pain and Inflammatory Bowel Diseases

2015 ◽  
Vol 61 (5) ◽  
pp. 553-557 ◽  
Author(s):  
Amit Assa ◽  
Alona Ish-Tov ◽  
Firas Rinawi ◽  
Raanan Shamir
2019 ◽  
Vol 31 (3) ◽  
pp. e13531 ◽  
Author(s):  
Luna Carpinelli ◽  
Cristina Bucci ◽  
Antonella Santonicola ◽  
Fabiana Zingone ◽  
Carolina Ciacci ◽  
...  

1990 ◽  
Vol 4 (7) ◽  
pp. 364-368 ◽  
Author(s):  
P Sherman ◽  
A Griffiths ◽  
M Marcon ◽  
C Smith ◽  
R Geist

The goals of therapy in chronic inflammatory bowel diseases in pediatrics include decreasing mucosa! inflammation, the restoration of optimal growth and pubertal development, and the return to a normal, age-appropriate lifestyle. The latter is best served by minimizing restrictions; for example, school attendance, extracurricular activities, travel and the child's interactions with both siblings and peers. In most instances dietary restrictions are also inappropriate and may prove detrimental. Children and adolescents are not simply 'little adults'. Teenagers dread being perceived as different from their peers. They are especially bothered therefore by cosmetic side effects associated with corticosteroid therapy and by impaired growth and pubertal development. Although not discussed openly, many adolescents are also concerned about their subsequent ability to have children and the potential for future development of neoplasms. The great majority of affected children adapt and function very well. Psychosocial factors, although clearly not the cause of inflammatory bowel diseases, are operative in many subsets of children with less than optimal function in daily activities. Children at particular risk are those with premorbid low self-esteem, dysfunction in family dynamics, or severe growth failure. Intervention and support provided through psychiatric and medical social work consultations and by the involvement of self-help groups are often key determinants for restoration of a normal lifestyle. Information about the underlying chronic disease, when provided at a level that is appropriate for age and cognitive function, can decrease anxiety and fears by reducing uncertainty and promoting a feeling of control.


2020 ◽  
Vol 10 (1) ◽  
pp. 31
Author(s):  
Patrycja Szałwińska ◽  
Jakub Włodarczyk ◽  
Antonino Spinelli ◽  
Jakub Fichna ◽  
Marcin Włodarczyk

Irritable bowel syndrome (IBS) is a functional heterogenous disease with a multifactorial pathogenesis. It is characterized by abdominal pain, discomfort, and alteration in gut motility. The occurrence of similar symptoms was observed in patients in clinical remission of inflammatory bowel diseases (IBD) that is Crohn’s disease (CD) and ulcerative colitis (UC), which pathogenesis is also not fully understood. Hence, arose the question if these symptoms are “true IBS” imposed on IBD, or is it a subclinical form of IBD or even pre-IBD? In this article, based on a narrative overview of the literature, we try to find an answer to this query by discussing the pathogenesis and overlaps between these conditions.


Nutrients ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 2583
Author(s):  
Martyna Jasielska ◽  
Urszula Grzybowska-Chlebowczyk

Background: A diet restricted in dairy products can cause calcium and vitamin D deficiency and, secondarily, lead to malnutrition and low bone mass. The aim of the study was to determine the incidence hypocalcemia and vitamin D deficiency in children with inflammatory bowel diseases and lactose intolerance (LI). Material and Methods: A total of 107 patients were enrolled to the study (mean age 14.07 ± 3.58 years; 46.7% boys): 43 with Crohn’s disease (CD), 31 with ulcerative colitis (UC), and 33 with functional abdominal pain (AP-FGID). Hydrogen breath test with lactose and laboratory tests to assess the calcium-phosphate metabolism were performed in all patients. The results of densitometry were interpreted in 37 IBD patients. Results: LI was diagnosed in 23.2% patients with CD, 22.6% with UC, and 21.2% children with AP-FGID, (p = 0.9). Moreover, 9.5% patients with CD, in 21.4% with UC, and in 51.5% with AP-FGID had optimal concentration of 25(OH)D (p = 0.0002). Hypocalcemia was diagnosed in 21% of patients with CD, 16.1% with UC patients, AP-FGID patients had normal calcium levels (p = 0.02). There was no difference in concentrations of total calcium, phosphorus, and 25(OH)D between patients on low-lactose diet and normal diet (p > 0.05). BMD Z-score ≤ −1 SD was obtained by 12 CD patients (48%), and 6 with UC (50%). Conclusion: The use of a low-lactose diet in the course of lactose intolerance in children with inflammatory bowel diseases has no effect on the incidence of calcium-phosphate disorders and reduced bone mineral density.


Sign in / Sign up

Export Citation Format

Share Document